Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies. (åbner nyt vindue)

Antun AG, Gleason S, Arellano M, Langston AA, McLemore ML, Gaddh M, el Rassi F, Bernal-Mizrachi L, Galipeau J, Heffner LT Jr, Winton EF, Khoury HJ.

Kilde‎: Cancer 2013;119(21):3784-7.

Indekseret‎: PubMed 23921838

DOI‎: 10.1002/cncr.28253

https://www.ncbi.nlm.nih.gov/pubmed/23921838 (åbner nyt vindue)

Low dose bolus aminocaproic acid: an alternative to platelet transfusion in thrombocytopenia? (åbner nyt vindue)

Chakrabarti S, Varma S, Singh S, Kumari S

Kilde‎: Eur J Haematol 1998;60(5):313-4.

Indekseret‎: PubMed 9654162

DOI‎: 10.1111/j.1600-0609.1998.tb01046.x

https://www.ncbi.nlm.nih.gov/pubmed/9654162 (åbner nyt vindue)

The use of antifibrinolytics in pediatric patients with hypoproliferative thrombocytopenia. (åbner nyt vindue)

Delaney M, Matthews DC, Gernsheimer TB

Kilde‎: Pediatr Blood Cancer 2017;64(12):e26641.

Indekseret‎: PubMed 28544698

DOI‎: 10.1002/pbc.26641

https://www.ncbi.nlm.nih.gov/pubmed/28544698 (åbner nyt vindue)

Preliminary experience with epsilon aminocaproic acid for treatment of intractable upper tract hematuria in children with hematological disorders. (åbner nyt vindue)

Kaye JD, Smith EA, Kirsch AJ, Cerwinka WH, Elmore JM

Kilde‎: J Urol 2010;184(3):1152-7.

Indekseret‎: PubMed 20650477

DOI‎: 10.1016/j.juro.2010.05.020

https://www.ncbi.nlm.nih.gov/pubmed/20650477 (åbner nyt vindue)

A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia. (åbner nyt vindue)

Shpilberg O, Blumenthal R, Sofer O, Katz Y, Chetrit A, Ramot B, Eldor A, Ben-Bassat I.

Kilde‎: Leuk Lymphoma 1995;19(1-2):141-4.

Indekseret‎: PubMed 8574160

DOI‎: 10.3109/10428199509059668

https://www.ncbi.nlm.nih.gov/pubmed/8574160 (åbner nyt vindue)

Pediatric off-label use of recombinant factor VIIa. (åbner nyt vindue)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

Kilde‎: Pediatrics 2009;123(3):1066-72.

Indekseret‎: PubMed 19255041

DOI‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (åbner nyt vindue)

Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience. (åbner nyt vindue)

Bhat S, Yadav SP, Anjan M, Dinand V, Sachdeva A.

Kilde‎: Indian J Pediatr 2011;78(8):961-8.

Indekseret‎: PubMed 21328080

DOI‎: 10.1007/s12098-011-0364-6

https://www.ncbi.nlm.nih.gov/pubmed/21328080 (åbner nyt vindue)

Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated Factor VII. (åbner nyt vindue)

Brenner B, Hoffman R, Balashov D, Shutluko E, Čulić SD, Nizamoutdinova E.

Kilde‎: Clin Appl Thromb Hemost 2005;11(4):401-10.

Indekseret‎: PubMed 16244765

https://www.ncbi.nlm.nih.gov/pubmed/16244765 (åbner nyt vindue)

Safety and efficacy of recombinant factor VIIa by pediatric age cohort: reassessment of compassionate use and trial data supporting US label. (åbner nyt vindue)

Croteau SE, Nakar C, Neufeld EJ, Shapiro A, Cooper DL

Kilde‎: Pediatr Blood Cancer 2016;63(10):1822-8.

Indekseret‎: PubMed 27232114

DOI‎: 10.1002/pbc.26082

https://www.ncbi.nlm.nih.gov/pubmed/27232114 (åbner nyt vindue)

Use of recombinant factor VIIa prior to lumbar puncture in pediatric patients with acute leukemia. (åbner nyt vindue)

Das P, Carcao M, Hitzler J

Kilde‎: Pediatr Blood Cancer 2006;47(2):206-9.

Indekseret‎: PubMed 16007583

DOI‎: 10.1002/pbc.20467

https://www.ncbi.nlm.nih.gov/pubmed/16007583 (åbner nyt vindue)

A comprehensive review of rFVIIa use in a tertiary care pediatric center. (åbner nyt vindue)

Heller M, Lau W, Pazmino-Canizares J, Brandão LR, Carcao M

Kilde‎: Pediatr Blood Cancer 2008;50(5):1013-7.

Indekseret‎: PubMed 17960639

DOI‎: 10.1002/pbc.21375

https://www.ncbi.nlm.nih.gov/pubmed/17960639 (åbner nyt vindue)

Recombinant activated factor VII for severe gastrointestinal bleeding after chemotherapy in an infant with acute megakaryoblastic leukemia. (åbner nyt vindue)

Kurekci AE, Atay AA, Okutan V, Yavuz ST, Ozcan O

Kilde‎: Blood Coagul Fibrinolysis 2005;16(2):145-7.

Indekseret‎: PubMed 15741803

DOI‎: 10.1097/01.mbc.0000161569.66764.70

https://www.ncbi.nlm.nih.gov/pubmed/15741803 (åbner nyt vindue)

Off-label use of recombinant factor VIIa in pediatric patients. (åbner nyt vindue)

McQuilten ZK, Barnes C, Zatta A, Phillips LE; Haemostasis Registry Steering Committee

Kilde‎: Pediatrics 2012;129(6):e1533-40.

Indekseret‎: PubMed 22641758

DOI‎: 10.1542/peds.2011-2561

https://www.ncbi.nlm.nih.gov/pubmed/22641758 (åbner nyt vindue)

Dosing, efficacy, and safety of recombinant factor VIIa (rFVIIa) in pediatric versus adult patients: the experience of the Hemostasis and Thrombosis Research Society (HTRS) registry (2004-2008). (åbner nyt vindue)

Neufeld EJ, Saxena K, Kessler CM, Cooper DL; HTRS Investigators

Kilde‎: Pediatr Blood Cancer 2013;60(7):1178-83.

Indekseret‎: PubMed 23335449

DOI‎: 10.1002/pbc.24472

https://www.ncbi.nlm.nih.gov/pubmed/23335449 (åbner nyt vindue)

Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII: report on one case and review of other uses in acute leukemias. (åbner nyt vindue)

Pamuk GE, Taşçi M, Oztürk E, Demir M.

Kilde‎: Med Oncol 2010;27(1):16-9.

Indekseret‎: PubMed 19137431

DOI‎: 10.1007/s12032-008-9163-y

https://www.ncbi.nlm.nih.gov/pubmed/19137431 (åbner nyt vindue)

Successful treatment of acute lymphoblastic leukemia with l-asparaginase-induced intracranial hemorrhage to activated recombinant factor VIIa in a child. (åbner nyt vindue)

Ucar C, Caliskan U

Kilde‎: Pediatr Hematol Oncol 2006;23(4):339-45.

Indekseret‎: PubMed 16621776

DOI‎: 10.1080/08880010600631987

https://www.ncbi.nlm.nih.gov/pubmed/16621776 (åbner nyt vindue)

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (åbner nyt vindue)

Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.

Kilde‎: Pediatr Hematol Oncol 2008;25(4):301-11.

Indekseret‎: PubMed 18484474

DOI‎: 10.1080/08880010802016904

https://www.ncbi.nlm.nih.gov/pubmed/18484474 (åbner nyt vindue)

The use of DDAVP in children with bleeding disorders. (åbner nyt vindue)

Ben-Ami T, Revel-Vilk S

Kilde‎: Pediatr Blood Cancer 2013;60 Suppl 1:S41-3.

Indekseret‎: PubMed 23109357

DOI‎: 10.1002/pbc.24335

https://www.ncbi.nlm.nih.gov/pubmed/23109357 (åbner nyt vindue)

Treatment of refractory thrombocytopenic bleeding with 1-desamino-8-D-arginine vasopressin (desmopressin). (åbner nyt vindue)

Kobrinsky NL, Tulloch H

Kilde‎: J Pediatr 1988;112(6):993-6.

Indekseret‎: PubMed 3373409

DOI‎: 10.1016/s0022-3476(88)80234-8

https://www.ncbi.nlm.nih.gov/pubmed/3373409 (åbner nyt vindue)

The use of Tachosil as hemostatic sealant in nephron sparing surgery for Wilms tumor: preliminary observations. (åbner nyt vindue)

Mele E, Ceccanti S, Schiavetti A, Bosco S, Masselli G, Cozzi DA

Kilde‎: J Pediatr Surg 2013;48(3):689-94.

Indekseret‎: PubMed 23480936

DOI‎: 10.1016/j.jpedsurg.2013.01.019

https://www.ncbi.nlm.nih.gov/pubmed/23480936 (åbner nyt vindue)